Literature DB >> 4479111

Editorial: Single daily dose of antidepressants.

F J Ayd.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4479111

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

Review 1.  Pharmacokinetic characterization of controlled-release formulations.

Authors:  V W Steinijans
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract.

Authors:  N M Graham
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

3.  Report of a workshop on fixed-ratio drug combinations.

Authors:  H J Dengler; L Lasagna
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

4.  Health care in the elderly: report of the Technical Group on Use of Medicaments by the Elderly. World Health Organization.

Authors: 
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 5.  Oral controlled release dosage forms. A review.

Authors:  P De Haan; C F Lerk
Journal:  Pharm Weekbl Sci       Date:  1984-04-27

Review 6.  Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

7.  Treatment of streptococcal pharyngitis with amoxycillin once a day.

Authors:  P Shvartzman; H Tabenkin; A Rosentzwaig; F Dolginov
Journal:  BMJ       Date:  1993-05-01

8.  Combination therapy in hypertension. A population-based study in eastern Finland.

Authors:  H Enlund; H Turakka; J Tuomilehto
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy.

Authors:  P J Rooney; H A Capell; S Paterson; W W Buchanan; W C Dick
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 10.  Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.

Authors:  Frieder Bauss; R Graham G Russell
Journal:  Osteoporos Int       Date:  2004-03-26       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.